Capital International Sarl’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-56,242
Closed -$1.66M 257
2023
Q4
$1.66M Buy
56,242
+3,106
+6% +$64.4K 0.06% 191
2023
Q3
$1.1M Buy
53,136
+4,866
+10% +$134K 0.05% 198
2023
Q2
$1.18M Buy
48,270
+478
+1% +$15.4K 0.05% 205
2023
Q1
$1.94M Buy
47,792
+7,403
+18% +$307K 0.1% 180
2022
Q4
$1.82M Buy
40,389
+13,929
+53% +$631K 0.13% 165
2022
Q3
$1.27M Buy
26,460
+7,420
+39% +$407K 0.1% 176
2022
Q2
$1.13M Buy
19,040
+2,667
+16% +$219K 0.09% 182
2022
Q1
$1.9M Sell
16,373
-2,842
-15% -$332K 0.09% 196
2021
Q4
$2.89M Buy
19,215
+15,664
+441% +$2.11M 0.14% 161
2021
Q3
$424K Sell
3,551
-175
-5% -$19.3K 0.04% 212
2021
Q2
$363K Buy
3,726
+185
+5% +$16.5K 0.03% 219
2021
Q1
$312K Buy
3,541
+279
+9% +$25.9K 0.03% 225
2020
Q4
$312K Buy
+3,262
New +$336K 0.03% 213

Other funds holding TNDM

Capital International Sarl's TNDM Position: Q1 2024 in Review

Capital International Sarl sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 56,242 shares — an estimated $1.66M sold.

Capital International Sarl first reported a position in TNDM in Q4 2020 and held it in 13 quarters. The position peaked at $2.89M in Q4 2021. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Capital International Sarl reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
  • Capital International Sarl sold 56,242 Tandem Diabetes Care shares in Q1 2024, an estimated $1.66M.
  • Capital International Sarl first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 13 quarters.
  • Capital International Sarl's Tandem Diabetes Care position peaked at $2.89M in Q4 2021.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Capital International Sarl's 13F filing for Q1 2024, filed 14 May 2024.